SAVA Stock – Knox Daily

Analysts Viewpoint

Cassava Sciences Inc’s filing revealed that its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0 on

Insiders Updates

Cassava Sciences Inc’s filing revealed that its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0 on

Insiders Updates

Cassava Sciences Inc’s filing revealed that its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0 on

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Cassava Sciences Inc’s recently made public that its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cassava Sciences

Featured

Cassava Sciences, Inc. (SAVA) has seen a push of 7.26% in the aftermarket because the company announced that petition filed

Featured

U.S. stocks posted broad declines yesterday as investors grew cautious in the wake of Fed Chairman Jay Powell’s Wednesday comments

Featured

The biotech company Cassava Sciences updates that its Alzheimer’s drug, sumifilam, recorded positive results in treating Alzheimer’s patients in a

Tag: SAVA Stock